| 1. |
cysteinyl-leukotriene
|
Asthma
|
M |
|
|
1 |
| 2. |
Methionine
|
Child Development Disorders, Pervasive
|
M |
|
|
1 |
| 3. |
S-(1,2,2-trichlorovinyl)-L-cysteine
|
Kidney Diseases
|
M |
|
|
1 |
| 4. |
Homocysteine
|
Glaucoma
|
M |
|
|
1 |
| 5. |
Homocysteine
|
Exfoliation Syndrome
|
M |
|
|
1 |
| 6. |
Methionine
|
Autistic Disorder
|
M |
Via 7 genes: GAD1; IFNG; IGF1; MIF; NOS2; RELN; SHANK3 |
56.51 |
11 |
| 7. |
selenomethylselenocysteine
|
Breast Neoplasms
|
M |
Via 8 genes: BCL2; CCND1; CDKN1B; ESR1; GPX1; GPX4; JUN; MKI67 |
52.16 |
11 |
| 8. |
Homocysteine
|
Autistic Disorder
|
M |
Via 6 genes: BCL2; CAT; COMT; GPX1; MECP2; MTHFR |
41.18 |
8 |
| 9. |
Homocysteine
|
Coronary Artery Disease
|
M |
Via 4 genes: CCL2; GPX1; NOS3; VEGFA |
35.36 |
5 |
| 10. |
Homocysteine
|
Schizophrenia
|
M |
Via 4 genes: CCL2; COMT; MTHFR; TP53 |
30.49 |
6 |
| 11. |
Homocysteine
|
Hyperhomocysteinemia
|
M |
Via 2 genes: MTHFR; MTRR |
20.33 |
7 |
| 12. |
S-Adenosylhomocysteine
|
Autistic Disorder
|
M |
Via 2 genes: COMT; SLC19A1 |
17.31 |
1 |
| 13. |
Homocysteine
|
Heart Defects, Congenital
|
M |
Via 2 genes: EDN1; MTHFR |
16.83 |
3 |
| 14. |
Homocysteine
|
Parkinson Disease
|
M |
Via 2 genes: GPX1; SOD1 |
14.45 |
2 |
| 15. |
S-Adenosylmethionine
|
Autistic Disorder
|
M |
Via 2 genes: COMT; SLC19A1 |
14.07 |
2 |
| 16. |
Cysteine
|
Autistic Disorder
|
M |
Via 2 genes: GSTM1; GSTP1 |
12.58 |
5 |
| 17. |
Homocysteine
|
Meningomyelocele
|
M |
Via 1 gene: MTHFR |
10.49 |
1 |
| 18. |
Ethionine
|
Blood Coagulation Disorders
|
M |
Via 1 gene: CFI |
8.65 |
2 |
| 19. |
Homocysteine
|
Myocardial Infarction
|
M |
Via 1 gene: NOS3 |
6.98 |
2 |
| 20. |
alliin
|
Neovascularization, Pathologic
|
T |
|
|
1 |
| 21. |
Methionine
|
Liver Cirrhosis, Experimental
|
T |
Via 9 genes: CYGB; IFNG; IGF1; NOS2; PDGFRB; TGFB1; TGFBR2; TIMP1; TNF |
70.58 |
19 |
| 22. |
Cysteine
|
Liver Cirrhosis, Experimental
|
T |
Via 8 genes: CYGB; GSTA2; GSTM1; HMOX1; PDGFRB; TGFB1; TGFBR2; TIMP1 |
65.15 |
16 |
| 23. |
Acetylcysteine
|
Drug-Induced Liver Injury
|
T |
Via 10 genes: ALB; BAX; CXCL1; GCLC; HMOX1; IL1B; IL6; MAP3K5; MMP2; PTGS2 |
64.59 |
10 |
| 24. |
Acetylcysteine
|
Carcinoma, Squamous Cell
|
T |
Via 9 genes: ALDH2; CDKN1A; HIF1A; IL8; MMP9; NFE2L2; PTGS2; STAT3; VEGFA |
59.85 |
9 |
| 25. |
Acetylcysteine
|
Neoplasm Metastasis
|
T |
Via 6 genes: DAPK1; EGFR; MMP2; MMP9; PLAU; TP53 |
43.86 |
6 |
| 26. |
S-allylcysteine
|
Prostatic Neoplasms
|
T |
Via 5 genes: BCL2; CDH1; JUP; KLK3; TGFB1 |
38.91 |
12 |
| 27. |
Acetylcysteine
|
Stomach Ulcer
|
T |
Via 3 genes: NOS2; PTGS2; TNF |
16.33 |
4 |
| 28. |
Acetylcysteine
|
Respiratory Distress Syndrome, Adult
|
T |
Via 2 genes: ALB; PLA2G4A |
15.66 |
3 |
| 29. |
S-Adenosylmethionine
|
Liver Cirrhosis, Experimental
|
T |
Via 2 genes: AFP; TGFB1 |
13.55 |
5 |
| 30. |
glutamyl-Se-methylselenocysteine
|
Breast Neoplasms
|
T |
Via 2 genes: CXCL2; JUN |
13.28 |
2 |
| 31. |
Acetylcysteine
|
Cystic Fibrosis
|
T |
Via 2 genes: CFTR; TGFB1 |
13.27 |
5 |
| 32. |
Acetylcysteine
|
Cell Transformation, Neoplastic
|
T |
Via 2 genes: MMP9; NOS2 |
12.63 |
2 |
| 33. |
Acetylcysteine
|
Lung Diseases
|
T |
Via 2 genes: TGFB1; TNF |
11.94 |
2 |
| 34. |
alliin
|
Neoplasms
|
T |
Via 1 gene: VEGFA |
8.50 |
2 |
| 35. |
S-allylcysteine
|
Pulmonary Fibrosis
|
T |
Via 1 gene: TGFB1 |
8.17 |
5 |
| 36. |
selenomethylselenocysteine
|
Mammary Neoplasms, Experimental
|
T |
Via 1 gene: SPP1 |
7.46 |
1 |
| 37. |
Acetylcysteine
|
Prostatic Neoplasms
|
|
Via 40 genes: AKT1; AR; ATM; BAX; BCL2; CASP9; CCND1; CDH13; CDKN1A; CDKN1B; CHEK2; CYP1A1; EGF; EGFR; EI24; FHIT; HERPUD1; HIF1A; ICAM1; IL24; IL6; IL8; INS; MMP9; NBN; NOS3; NQO1; NR3C1; PARP1; PLAU; PTGS2; SOD2; STAT3; TERT; TGFB1; TGFBR2; TNFSF10; TP53; VEGFA; ZFP36L2 |
267.65 |
63 |
| 38. |
Acetylcysteine
|
Breast Neoplasms
|
|
Via 28 genes: AKT1; ATM; BCL2; CASP8; CCND1; CDKN1B; CHEK2; CXCL2; CYP1A1; EGF; EGFR; FOS; HMOX1; IL1B; IL24; IL6; IL8; JUN; MMP3; NFKBIA; NOS2; NQO1; PTGS2; SNAI1; STAT3; TANK; TNF; TP53 |
180.37 |
27 |
| 39. |
Ethionine
|
Liver Cirrhosis, Experimental
|
|
Via 19 genes: ABCB1A; ADH4; AFP; AGT; AGTR1A; ALDH1A1; ALDH2; CDO1; CES2; FMO1; GULO; HAO2; IGF1; IGFBP2; INHBE; KRT8; OBP3; PLG; RNASE4 |
136.16 |
7 |
| 40. |
Acetylcysteine
|
Lung Neoplasms
|
|
Via 20 genes: CASP8; CCND1; CDKN1A; CDKN1B; DAPK1; EGFR; FHIT; FOS; HMOX1; IL24; JUNB; MAPK1; MAPK14; MAPK3; NOS2; TERT; TGFB1; TGFBR2; TNF; TP53 |
132.38 |
25 |
| 41. |
Ethionine
|
Prostatic Neoplasms
|
|
Via 19 genes: ARL6IP1; BNIP3; CBR1; CLPTM1L; CSRP1; DCXR; DNAJC3; ERP29; GSTT1; IGF1; NR3C1; PDIA3; PGRMC1; PRDX2; RNASE4; RPN2; RPS19; SERINC3; SURF4 |
128.61 |
9 |
| 42. |
Acetylcysteine
|
Liver Cirrhosis, Experimental
|
|
Via 18 genes: ADIPOQ; AGT; ALDH2; CCL2; EDN1; FGF2; HGF; HMOX1; ID2; IL1B; MMP2; MMP9; NOS2; PTGS2; TGFB1; TGFBR2; TNF; VEGFA |
114.39 |
26 |
| 43. |
Acetylcysteine
|
Stomach Neoplasms
|
|
Via 17 genes: CASP8; CDKN1A; CDKN1B; EGFR; FHIT; HBEGF; HMOX1; IL1B; IL8; JUN; MAPK8; NOS3; PLAU; PTGS2; SNAI1; SOD2; TNF |
111.12 |
13 |
| 44. |
Acetylcysteine
|
Pulmonary Fibrosis
|
|
Via 12 genes: CCL2; CCL5; CXCL2; EGF; FGF2; HGF; HMOX1; IL1B; IL6; IL8; TGFB1; TNF |
89.00 |
10 |
| 45. |
Acetylcysteine
|
Colorectal Neoplasms
|
|
Via 13 genes: AKT1; ALDH2; BCL2; CASP8; CCND1; CHEK2; EGFR; PPARG; PTGS2; TGFBR1; TNFSF10; TP53; TXNRD1 |
86.64 |
19 |
| 46. |
Acetylcysteine
|
Carcinoma, Hepatocellular
|
|
Via 13 genes: AR; CASP8; CDH13; CYP1A1; EGF; EGFR; FOS; HTATIP2; IL6; PTGS2; TERT; TGFB1; TP53 |
85.95 |
12 |
| 47. |
Buthionine Sulfoximine
|
Breast Neoplasms
|
|
Via 13 genes: BCL2; CCND1; CDKN1B; CYP1A1; FOS; HMOX1; IL6; JUN; NOS2; NQO1; STAT3; TNF; TP53 |
85.90 |
15 |
| 48. |
Buthionine Sulfoximine
|
Prostatic Neoplasms
|
|
Via 13 genes: BCL2; CCND1; CDKN1A; CDKN1B; CYP1A1; HIF1A; IL10; IL6; NQO1; SOD2; STAT3; TGFBR2; TP53 |
84.44 |
21 |
| 49. |
Acetylcysteine
|
Reperfusion Injury
|
|
Via 10 genes: CDKN1A; CXCL1; EFNB2; EGF; FGF2; HGF; KDR; SELE; TERT; TNF |
81.43 |
4 |
| 50. |
selenomethylselenocysteine
|
Prostatic Neoplasms
|
|
Via 12 genes: AR; BCL2; CCND1; CDKN1B; CYP3A5; ESR1; FASLG; GADD45A; KLK3; PRKCZ; SEPP1; TNFSF10 |
81.34 |
28 |
| 51. |
Buthionine Sulfoximine
|
Lung Neoplasms
|
|
Via 11 genes: CCND1; CDKN1A; CDKN1B; FOS; HMOX1; IL10; JUNB; NOS2; TGFBR2; TNF; TP53 |
79.08 |
12 |
| 52. |
Acetylcysteine
|
Esophageal Neoplasms
|
|
Via 11 genes: ALDH2; BAX; CASP8; CCND1; CDH13; CDKN1A; HIF1A; NOS2; PTGS2; TGFBR2; TP53 |
77.69 |
14 |
| 53. |
Acetylcysteine
|
Asthma
|
|
Via 11 genes: ALDH2; BCL2; CAT; CCL2; CD14; HMOX1; ICAM1; MMP9; TGFB1; TNF; VEGFA |
74.15 |
16 |
| 54. |
Acetylcysteine
|
Oral Submucous Fibrosis
|
|
Via 8 genes: COL1A1; COL1A2; FGF2; MMP2; MMP9; PTGS2; TGFB1; TNF |
66.24 |
1 |
| 55. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Prostatic Neoplasms
|
|
Via 10 genes: ATF3; CCND1; CDKN1A; CREG1; EIF2AK2; GADD45A; GDF15; HSPA1A; TOP2A; VEGFA |
65.84 |
13 |
| 56. |
Selenomethionine
|
Prostatic Neoplasms
|
|
Via 10 genes: AR; EGFR; GPX3; GSTP1; HPN; IL8; KLK3; PRKCZ; TGFBR2; TP53 |
63.90 |
29 |
| 57. |
Acetylcysteine
|
Liver Cirrhosis
|
|
Via 8 genes: FGF2; HGF; IL6; IL8; MMP2; PLAU; SPP1; STAT1 |
61.39 |
7 |
| 58. |
Selenomethionine
|
Lung Neoplasms
|
|
Via 9 genes: EGFR; FOS; GPX1; GPX3; GSTP1; MAPK1; MAPK3; TGFBR2; TP53 |
60.34 |
11 |
| 59. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
HIV Infections
|
|
Via 7 genes: BAG3; BIRC3; CDKN1A; GADD45A; HSP90AA1; HSPB1; MDM2 |
59.88 |
2 |
| 60. |
Acetylcysteine
|
Liver Diseases
|
|
Via 9 genes: CCL2; CD86; HMOX1; MMP9; NFKB1; NOS2; NQO1; SOD1; TXN |
58.02 |
10 |
| 61. |
Acetylcysteine
|
Coronary Artery Disease
|
|
Via 7 genes: CCL2; CD40LG; HMOX1; NOS3; PTGS2; TERT; VEGFA |
57.29 |
7 |
| 62. |
S-Nitroso-N-Acetylpenicillamine
|
Hernia, Diaphragmatic
|
|
Via 6 genes: EDN1; ELN; FGF2; NPPA; SFTPB; SFTPC |
56.84 |
8 |
| 63. |
Homocysteine
|
Prostatic Neoplasms
|
|
Via 9 genes: BAX; BCL2; COMT; MMP9; MTHFR; NOS3; TP53; VEGFA; VIM |
56.56 |
13 |
| 64. |
Acetylcysteine
|
Hernia, Diaphragmatic
|
|
Via 8 genes: AGT; EDN1; FGF2; ICAM1; IL6; NOS3; TGFB1; TNF |
55.12 |
10 |
| 65. |
Acetylcysteine
|
Mesothelioma
|
|
Via 7 genes: CDKN1B; DIO2; FGF2; FHIT; SOD2; SPP1; TXNRD1 |
54.68 |
9 |
| 66. |
Acetylcysteine
|
Alzheimer Disease
|
|
Via 9 genes: BAX; BCL2; CASP3; HMOX1; IL1B; NOS3; PLAU; PPARG; TNF |
54.58 |
7 |
| 67. |
lactacystin
|
Breast Neoplasms
|
|
Via 8 genes: CCND1; CDKN1B; COMT; CTNNB1; IL6; IL8; TNF; TP53 |
54.18 |
13 |
| 68. |
lactacystin
|
Prostatic Neoplasms
|
|
Via 8 genes: CCND1; CDKN1B; COMT; CTNNB1; HIF1A; IL6; IL8; TP53 |
52.32 |
11 |
| 69. |
S-Nitroso-N-Acetylpenicillamine
|
Liver Cirrhosis, Experimental
|
|
Via 7 genes: EDN1; FGF2; GOT1; GSTA2; HMOX1; IFNG; MME |
52.12 |
10 |
| 70. |
S-Adenosylmethionine
|
Prostatic Neoplasms
|
|
Via 7 genes: ATF3; COMT; CYP2E1; GNMT; KLF6; RNASEL; TGFB1 |
51.40 |
9 |
| 71. |
S-Nitroso-N-Acetylpenicillamine
|
Lung Neoplasms
|
|
Via 7 genes: GPX1; HMOX1; MAPK1; MAPK3; NPPA; SFTPB; TP53 |
50.19 |
10 |
| 72. |
Acetylcysteine
|
Carcinoma, Non-Small-Cell Lung
|
|
Via 7 genes: DAPK1; FHIT; GCLC; IL8; NQO1; TP53; VEGFA |
49.51 |
6 |
| 73. |
Acetylcysteine
|
Autistic Disorder
|
|
Via 9 genes: AR; BCL2; CAT; EGF; EGR2; IL6; NOS2; PLA2G4A; PTGS2 |
49.18 |
9 |
| 74. |
Buthionine Sulfoximine
|
Liver Cirrhosis, Experimental
|
|
Via 7 genes: GPT; HMOX1; IGFBP1; IL10; NOS2; TGFBR2; TNF |
48.23 |
16 |
| 75. |
Acetylcysteine
|
Skin Neoplasms
|
|
Via 7 genes: CASP8; FLT1; HIF1A; MMP9; NFE2L2; PTGS2; TGFB1 |
48.19 |
6 |
| 76. |
Acetylcysteine
|
Liver Neoplasms
|
|
Via 7 genes: CDKN1B; FHIT; HMOX1; MAPK14; STAT3; TNFSF10; TP53 |
47.76 |
8 |
| 77. |
Acetylcysteine
|
Colonic Neoplasms
|
|
Via 8 genes: BCL2; CCND1; ICAM1; IL1B; MMP9; TNFSF10; TP53; VEGFA |
47.70 |
9 |
| 78. |
Acetylcysteine
|
Cardiomegaly
|
|
Via 6 genes: AGT; ATP2A2; FGF2; NOS3; PLD1; PLD2 |
47.68 |
6 |
| 79. |
Methionine
|
Oral Submucous Fibrosis
|
|
Via 5 genes: COL1A1; IFNG; TGFB1; TIMP1; TNF |
47.64 |
1 |
| 80. |
Homocysteine
|
Breast Neoplasms
|
|
Via 7 genes: BCL2; COMT; GPX1; MTHFR; MTR; NFKBIA; TP53 |
47.18 |
14 |
| 81. |
Acetylcysteine
|
Pancreatic Neoplasms
|
|
Via 7 genes: CYP2B1; HIF1A; IL24; PLAU; PTGS2; TNF; TP53 |
47.16 |
10 |
| 82. |
Cysteine
|
Prostatic Neoplasms
|
|
Via 7 genes: AKT1; CCND1; CDKN1B; GSTM1; GSTP1; TGFB1; TGFBR2 |
47.07 |
10 |
| 83. |
S-Nitroso-N-Acetylpenicillamine
|
Prostatic Neoplasms
|
|
Via 7 genes: BCL2; CALCA; HSD3B1; MME; NPPA; SOD2; TP53 |
46.62 |
10 |
| 84. |
Buthionine Sulfoximine
|
Esophageal Neoplasms
|
|
Via 6 genes: CCND1; CDKN1A; HIF1A; NOS2; TGFBR2; TP53 |
46.08 |
6 |
| 85. |
S-nitro-N-acetylpenicillamine
|
Breast Neoplasms
|
|
Via 6 genes: BIRC5; CYP19A1; IL6; JUN; PTGS2; STAT3 |
45.89 |
8 |
| 86. |
Ethionine
|
Stomach Neoplasms
|
|
Via 7 genes: BNIP3; CA2; DPYD; ENO1; KRT8; PGAM1; SERPINA1 |
45.65 |
5 |
| 87. |
Cysteine
|
Lung Neoplasms
|
|
Via 6 genes: CCND1; CDKN1B; GSTP1; HMOX1; TGFB1; TGFBR2 |
45.07 |
10 |
| 88. |
S-nitro-N-acetylpenicillamine
|
Prostatic Neoplasms
|
|
Via 6 genes: BNIP3; CALCA; CYP19A1; IL6; PTGS2; STAT3 |
44.94 |
11 |
| 89. |
selenomethylselenocysteine
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Via 4 genes: ARNTL; CRY2; PER2; PER3 |
44.74 |
1 |
| 90. |
Acetylcysteine
|
Sepsis
|
|
Via 6 genes: CASP3; MAPK1; MAPK3; MMP9; TGFB1; TNF |
44.28 |
2 |
| 91. |
Homocysteine
|
Cardiovascular Diseases
|
|
Via 5 genes: CCL2; EDN1; GH1; MTHFR; VCAM1 |
44.02 |
3 |
| 92. |
Acetylcysteine
|
Carcinoma, Transitional Cell
|
|
Via 5 genes: APAF1; CDKN1A; DAPK1; PLAU; PTGS2 |
43.88 |
6 |
| 93. |
Acetylcysteine
|
Diabetes Mellitus, Type 2
|
|
Via 7 genes: CAT; EDN1; HMOX1; IL6; NFKB1; PPARG; VEGFA |
43.65 |
5 |
| 94. |
Buthionine Sulfoximine
|
Colorectal Neoplasms
|
|
Via 6 genes: BCL2; CCND1; PPARG; TGFBR1; TP53; TXNRD1 |
43.50 |
11 |
| 95. |
lactacystin
|
Lung Neoplasms
|
|
Via 6 genes: BCL2L1; CCND1; CDKN1B; CTNNB1; TNF; TP53 |
42.36 |
10 |
| 96. |
Ethionine
|
Carcinoma, Hepatocellular
|
|
Via 6 genes: ADD1; AFP; APCS; DPYD; GJB1; PYGL |
42.25 |
6 |
| 97. |
Acetylcysteine
|
Glioma
|
|
Via 6 genes: MGMT; PPARG; PTGS2; SPP1; TERT; TP53 |
42.16 |
7 |
| 98. |
Acetylcysteine
|
Glioblastoma
|
|
Via 6 genes: EGF; IL1B; IL8; MMP2; MMP9; VEGFA |
41.19 |
2 |
| 99. |
Homocysteine
|
Liver Cirrhosis, Experimental
|
|
Via 6 genes: ACHE; CCL2; EDN1; GH1; MMP9; VEGFA |
40.93 |
7 |
| 100. |
Acetylcysteine
|
Arsenic Poisoning
|
|
Via 6 genes: CXCL2; ID2; IL1B; SOD2; TNF; TP53 |
39.29 |
3 |
| 101. |
Buthionine Sulfoximine
|
Stomach Neoplasms
|
|
Via 6 genes: CDKN1A; CDKN1B; HMOX1; JUN; SOD2; TNF |
39.24 |
5 |
| 102. |
Methionine
|
Breast Neoplasms
|
|
Via 6 genes: ABCG2; AKT1; IFNG; IGF1; NOS2; TNF |
39.07 |
6 |
| 103. |
selenomethylselenocysteine
|
Leukemia
|
|
Via 5 genes: AR; BCL2; CCND1; ESR1; PRKCZ |
38.89 |
5 |
| 104. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Breast Neoplasms
|
|
Via 6 genes: BIRC5; CCND1; FHL2; HMOX1; HSPA1B; TOP2A |
38.70 |
8 |
| 105. |
Acetylcysteine
|
Skin Diseases
|
|
Via 6 genes: CXCL2; ID2; IL1B; PTGS2; SOD2; TNF |
38.63 |
2 |
| 106. |
Acetylcysteine
|
Amyotrophic Lateral Sclerosis
|
|
Via 5 genes: CD40LG; PLA2G4A; PTGS2; SOD1; TP53 |
37.77 |
9 |
| 107. |
Buthionine Sulfoximine
|
Diabetes Mellitus, Type 2
|
|
Via 5 genes: CAT; HMOX1; IL6; INS1; PPARG |
37.57 |
4 |
| 108. |
Acetylcysteine
|
Carcinoma, Renal Cell
|
|
Via 5 genes: APAF1; DAPK1; FLT1; PTGS2; TP53 |
37.48 |
4 |
| 109. |
Acetylcysteine
|
Cardiovascular Diseases
|
|
Via 5 genes: CCL2; EDN1; ICAM1; PON2; SELE |
37.32 |
2 |
| 110. |
lactacystin
|
Carcinoma, Hepatocellular
|
|
Via 5 genes: BCL2L1; COMT; CTNNB1; IL6; TP53 |
37.09 |
8 |
| 111. |
N-Formylmethionine Leucyl-Phenylalanine
|
Breast Neoplasms
|
|
Via 6 genes: AKT1; IL1B; IL6; IL8; PTGS2; TNF |
36.71 |
6 |
| 112. |
selenomethylselenocysteine
|
Colorectal Neoplasms
|
|
Via 5 genes: BCL2; CCND1; GPX4; SEPP1; TNFSF10 |
36.65 |
5 |
| 113. |
Homocysteine
|
Alzheimer Disease
|
|
Via 5 genes: APP; BAX; BCL2; MTHFR; NOS3 |
36.51 |
15 |
| 114. |
Homocysteine
|
Asthma
|
|
Via 5 genes: BCL2; CAT; CCL2; MMP9; VEGFA |
36.32 |
7 |
| 115. |
Selenomethionine
|
Neoplasm Recurrence, Local
|
|
Via 4 genes: AR; GRK6; KLK3; PARVB |
36.20 |
3 |
| 116. |
Ethionine
|
Adenocarcinoma
|
|
Via 5 genes: CA2; ENO1; KRT8; PGAM1; SERPINA1 |
35.60 |
1 |
| 117. |
Homocysteine
|
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE
|
|
Via 3 genes: MTHFR; MTR; MTRR |
35.60 |
1 |
| 118. |
S-(1,2-dichlorovinyl)cysteine
|
Prostatic Neoplasms
|
|
Via 5 genes: BAX; BCL2; CASP9; PARP1; TP53 |
35.49 |
6 |
| 119. |
Buthionine Sulfoximine
|
Asthma
|
|
Via 5 genes: BCL2; CAT; HMOX1; IL12B; TNF |
35.39 |
6 |
| 120. |
N-Formylmethionine Leucyl-Phenylalanine
|
Fever
|
|
Via 4 genes: IL1B; IL6; IL8; TNF |
35.21 |
1 |
| 121. |
Acetylcysteine
|
Obesity
|
|
Via 5 genes: ADIPOQ; CPE; ICAM1; NQO1; PPARG |
35.16 |
5 |
| 122. |
Acetylcysteine
|
Myocardial Infarction
|
|
Via 5 genes: GCLC; GCLM; NOS2; NOS3; OLR1 |
35.13 |
7 |
| 123. |
Homocysteine
|
Colonic Neoplasms
|
|
Via 5 genes: BCL2; MMP9; MTHFR; TP53; VEGFA |
35.06 |
7 |
| 124. |
S-Nitroso-N-Acetylpenicillamine
|
Pulmonary Fibrosis
|
|
Via 4 genes: CALCA; ELN; FGF2; HMOX1 |
34.98 |
4 |
| 125. |
Selenomethionine
|
Autistic Disorder
|
|
Via 5 genes: AR; GPX1; GSTP1; LASP1; SEMA5A |
34.67 |
5 |
| 126. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Colorectal Neoplasms
|
|
Via 5 genes: BIRC5; CCND1; PPARG; TK1; TXNRD1 |
34.67 |
5 |
| 127. |
Buthionine Sulfoximine
|
Mesothelioma
|
|
Via 4 genes: CDKN1B; DIO2; SOD2; TXNRD1 |
34.28 |
5 |
| 128. |
Ethionine
|
Metabolism, Inborn Errors
|
|
Via 4 genes: ACACA; DECR1; MUT; OGDH |
34.28 |
4 |
| 129. |
selenomethylselenocysteine
|
Lung Neoplasms
|
|
Via 5 genes: CCND1; CDKN1B; ESR1; GPX1; SEPP1 |
33.88 |
8 |
| 130. |
Acetylcysteine
|
Psoriasis
|
|
Via 5 genes: IL6; TNF; TNFAIP3; TP53; VEGFA |
33.74 |
4 |
| 131. |
Ethionine
|
Colorectal Neoplasms
|
|
Via 5 genes: ALDH2; DPYD; GGH; GPX4; NME2 |
33.63 |
7 |
| 132. |
Buthionine Sulfoximine
|
Alzheimer Disease
|
|
Via 5 genes: BCL2; CASP3; HMOX1; PPARG; TNF |
33.62 |
4 |
| 133. |
N-Formylmethionine Leucyl-Phenylalanine
|
Lung Neoplasms
|
|
Via 5 genes: MAPK1; MAPK14; MAPK3; MPO; TNF |
33.59 |
5 |
| 134. |
Selenomethionine
|
Breast Neoplasms
|
|
Via 6 genes: EGFR; FOS; GPX1; IL1B; IL8; TP53 |
33.59 |
9 |
| 135. |
Methionine
|
Prostatic Neoplasms
|
|
Via 5 genes: AKT1; IGF1; MIF; TGFB1; TGFBR2 |
33.37 |
6 |
| 136. |
Acetylcysteine
|
Myocardial Ischemia
|
|
Via 4 genes: FGF2; HGF; NOS3; VEGFA |
33.24 |
6 |
| 137. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Liver Cirrhosis, Experimental
|
|
Via 5 genes: CYP3A13; GSTA2; HGF; HMOX1; VEGFA |
33.24 |
12 |
| 138. |
Cysteine
|
Breast Neoplasms
|
|
Via 5 genes: AKT1; CCND1; CDKN1B; HMOX1; RB1 |
33.15 |
5 |
| 139. |
Acetylcysteine
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Via 5 genes: ATM; CCND1; IL6; PTGS2; TP53 |
33.10 |
5 |
| 140. |
N-Formylmethionine Leucyl-Phenylalanine
|
Stomach Neoplasms
|
|
Via 5 genes: IL1B; IL8; MAPK8; PTGS2; TNF |
33.07 |
6 |
| 141. |
Acetylcysteine
|
Hypertension
|
|
Via 5 genes: AGT; EDN1; INS; NOS3; PTGS2 |
32.73 |
10 |
| 142. |
Buthionine Sulfoximine
|
Colitis, Ulcerative
|
|
Via 4 genes: IL10; IL12B; RELA; STAT3 |
32.56 |
5 |
| 143. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Stomach Neoplasms
|
|
Via 5 genes: BIRC5; CDKN1A; GADD45A; HMOX1; IRF1 |
32.47 |
4 |
| 144. |
Homocysteine
|
Lung Neoplasms
|
|
Via 5 genes: GPX1; MAPK1; MAPK3; MTHFR; TP53 |
32.31 |
7 |
| 145. |
S-Adenosylmethionine
|
Carcinoma, Hepatocellular
|
|
Via 4 genes: AFP; COMT; TGFB1; UBD |
32.28 |
4 |
| 146. |
S-nitro-N-acetylpenicillamine
|
Stomach Neoplasms
|
|
Via 4 genes: BIRC5; BNIP3; JUN; PTGS2 |
32.14 |
4 |
| 147. |
Ethionine
|
Lung Neoplasms
|
|
Via 5 genes: CLPTM1L; DPYD; GJB1; GPX1; SERPINA1 |
32.06 |
6 |
| 148. |
Acetylcysteine
|
Adenocarcinoma
|
|
Via 5 genes: DAPK1; PLAU; PTGS2; TGFB1; TP53 |
31.90 |
8 |
| 149. |
selenomethylselenocysteine
|
Mesothelioma
|
|
Via 4 genes: CDKN1B; ESR1; PGR; SPP1 |
31.85 |
4 |
| 150. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Lung Neoplasms
|
|
Via 5 genes: BIRC5; CCND1; CDKN1A; HMOX1; IRF1 |
31.69 |
8 |
| 151. |
S-Adenosylmethionine
|
Down Syndrome
|
|
Via 3 genes: GSTM2; MTR; SLC19A1 |
31.45 |
4 |
| 152. |
N-Formylmethionine Leucyl-Phenylalanine
|
Skin Diseases
|
|
Via 4 genes: IL1B; PTGS2; TNF; TNFAIP6 |
31.40 |
2 |
| 153. |
Selenomethionine
|
Carcinoma, Hepatocellular
|
|
Via 5 genes: AR; EGFR; FOS; GSTP1; TP53 |
31.39 |
5 |
| 154. |
Cysteine
|
Asthma
|
|
Via 4 genes: GSTM1; GSTP1; HMOX1; TGFB1 |
31.24 |
5 |
| 155. |
Acetylcysteine
|
Schizophrenia
|
|
Via 5 genes: AKT1; BTG1; CCL2; IL1B; TP53 |
31.11 |
5 |
| 156. |
Acetylcysteine
|
Urinary Bladder Neoplasms
|
|
Via 5 genes: CDKN1A; EGFR; PTGS2; TERT; TP53 |
31.03 |
8 |
| 157. |
Homocysteine
|
Lymphoma, Follicular
|
|
Via 3 genes: BCL2; MTHFR; MTR |
30.93 |
3 |
| 158. |
Acetylcysteine
|
Arthritis, Rheumatoid
|
|
Via 5 genes: MMP2; PTGS2; TNF; TNFAIP3; VEGFA |
30.91 |
7 |
| 159. |
Acetylcysteine
|
HYPERTENSION, ESSENTIAL
|
|
Via 4 genes: AGT; NOS2; NOS3; SELE |
30.89 |
1 |
| 160. |
Selenomethionine
|
Head and Neck Neoplasms
|
|
Via 4 genes: EGFR; GPX1; MAPK1; MAPK3 |
30.84 |
2 |
| 161. |
Acetylcysteine
|
Cholangiocarcinoma
|
|
Via 4 genes: EGFR; IL6; NOS2; PTGS2 |
30.79 |
3 |
| 162. |
Acetylcysteine
|
Craniofacial Abnormalities
|
|
Via 5 genes: APAF1; EDN1; EGFR; MMP2; TGFBR2 |
30.69 |
10 |
| 163. |
Selenomethionine
|
Colonic Neoplasms
|
|
Via 4 genes: GRK6; IL1B; PARVB; TP53 |
30.68 |
4 |
| 164. |
N-Formylmethionine Leucyl-Phenylalanine
|
Pulmonary Fibrosis
|
|
Via 4 genes: IL1B; IL6; IL8; TNF |
30.56 |
4 |
| 165. |
Acetylcysteine
|
Carcinoma
|
|
Via 4 genes: BCL2; EGFR; FHIT; PTGS2 |
30.55 |
4 |
| 166. |
S-Nitroso-N-Acetylpenicillamine
|
Breast Neoplasms
|
|
Via 5 genes: BCL2; GPX1; HMOX1; IFNG; TP53 |
30.35 |
10 |
| 167. |
N,N-diacetylcystine
|
Arthritis, Rheumatoid
|
|
Via 3 genes: IL2RA; PTPRC; TNF |
30.27 |
3 |
| 168. |
Buthionine Sulfoximine
|
Psoriasis
|
|
Via 4 genes: IL12B; IL6; TNF; TP53 |
30.22 |
5 |
| 169. |
Acetylcysteine
|
Berylliosis
|
|
Via 4 genes: GCLM; IL6; TGFB1; TNF |
30.14 |
7 |
| 170. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Carcinoma, Non-Small-Cell Lung
|
|
Via 4 genes: ATF3; BIRC5; GCLC; VEGFA |
30.11 |
4 |
| 171. |
Buthionine Sulfoximine
|
Carcinoma, Squamous Cell
|
|
Via 4 genes: CDKN1A; HIF1A; NFE2L2; STAT3 |
30.07 |
4 |
| 172. |
Acetylcysteine
|
Ovarian Neoplasms
|
|
Via 5 genes: AKT1; CDKN1B; EGFR; MAPK1; MAPK3 |
29.93 |
2 |
| 173. |
Selenomethionine
|
Craniofacial Abnormalities
|
|
Via 4 genes: COL2A1; EGFR; TBX1; TGFBR2 |
29.82 |
7 |
| 174. |
S-allylcysteine
|
Breast Neoplasms
|
|
Via 4 genes: BCL2; CASP8; CDH1; NOS2 |
29.69 |
8 |
| 175. |
Buthionine Sulfoximine
|
Liver Neoplasms
|
|
Via 4 genes: CDKN1B; HMOX1; STAT3; TP53 |
29.39 |
5 |
| 176. |
Buthionine Sulfoximine
|
Autistic Disorder
|
|
Via 5 genes: BCL2; CAT; IL10; IL6; NOS2 |
29.26 |
5 |
| 177. |
Homocysteine
|
Colorectal Neoplasms
|
|
Via 4 genes: BCL2; MTHFR; MTRR; TP53 |
29.20 |
16 |
| 178. |
Acetylcysteine
|
Osteoporosis, Postmenopausal
|
|
Via 4 genes: CAT; IL1B; IL6; TNF |
29.04 |
2 |
| 179. |
Homocysteine
|
Liver Diseases
|
|
Via 4 genes: CCL2; MMP9; MTHFR; SOD1 |
28.95 |
4 |
| 180. |
N-Formylmethionine Leucyl-Phenylalanine
|
Prostatic Neoplasms
|
|
Via 5 genes: AKT1; IL6; IL8; PTGS2; VEGFA |
28.90 |
11 |
| 181. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Colonic Neoplasms
|
|
Via 4 genes: BIRC5; CCND1; KLF13; VEGFA |
28.78 |
4 |
| 182. |
Cysteine
|
Oral Submucous Fibrosis
|
|
Via 3 genes: COL1A1; TGFB1; TIMP1 |
28.67 |
1 |
| 183. |
Homocysteine
|
Infertility, Male
|
|
Via 3 genes: MTHFR; MTR; MTRR |
28.54 |
1 |
| 184. |
Ethionine
|
Breast Neoplasms
|
|
Via 5 genes: AFP; DPYD; GPX1; GPX4; IGF1 |
28.41 |
5 |
| 185. |
N-Formylmethionine Leucyl-Phenylalanine
|
Leukemia, Promyelocytic, Acute
|
|
Via 3 genes: AKT1; ITGAM; ITGB2 |
28.19 |
2 |
| 186. |
Acetylcysteine
|
Melanoma
|
|
Via 5 genes: CASP8; FLT1; PTGS2; TNF; TP53 |
28.06 |
6 |
| 187. |
Ethionine
|
Drug-Induced Liver Injury
|
|
Via 4 genes: APOH; ENO1; GSTT1; PZP |
27.98 |
2 |
| 188. |
S-Adenosylmethionine
|
Oral Submucous Fibrosis
|
|
Via 3 genes: COL1A1; COL1A2; TGFB1 |
27.92 |
1 |
| 189. |
Methionine
|
Sepsis
|
|
Via 3 genes: MIF; TGFB1; TNF |
27.89 |
3 |
| 190. |
Acetylcysteine
|
Fever
|
|
Via 4 genes: IL1B; IL6; IL8; TNF |
27.66 |
1 |
| 191. |
Acetylcysteine
|
Multiple Myeloma
|
|
Via 4 genes: BTG1; CCL2; CCND1; NQO1 |
27.50 |
3 |
| 192. |
Buthionine Sulfoximine
|
Liver Diseases
|
|
Via 4 genes: HMOX1; NOS2; NQO1; SOD1 |
27.15 |
7 |
| 193. |
Methionine
|
Lung Neoplasms
|
|
Via 4 genes: NOS2; TGFB1; TGFBR2; TNF |
27.05 |
5 |
| 194. |
Acetylcysteine
|
Osteoporosis
|
|
Via 4 genes: COL1A1; COL1A2; IL6; TGFB1 |
27.01 |
3 |
| 195. |
Selenomethionine
|
Liver Cirrhosis, Experimental
|
|
Via 4 genes: IL1B; MMP1; PLG; TGFBR2 |
26.85 |
5 |
| 196. |
S-Adenosylhomocysteine
|
OSTEOGENESIS IMPERFECTA, TYPE IV
|
|
Via 2 genes: COL1A1; COL1A2 |
26.82 |
1 |
| 197. |
S-Adenosylhomocysteine
|
EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT
|
|
Via 2 genes: COL1A1; COL1A2 |
26.82 |
1 |
| 198. |
lactacystin
|
Stomach Neoplasms
|
|
Via 4 genes: CDKN1B; IL8; MAPK8; TNF |
26.73 |
4 |
| 199. |
Acetylcysteine
|
Myocardial Stunning
|
|
Via 3 genes: ATP2A2; NOS2; TNF |
26.59 |
2 |
| 200. |
Ethionine
|
Carcinoma, Squamous Cell
|
|
Via 4 genes: ALDH2; CSNK2B; GPX1; GSTT1 |
26.35 |
4 |
| 201. |
N-Formylmethionine Leucyl-Phenylalanine
|
Osteoporosis, Postmenopausal
|
|
Via 3 genes: IL1B; IL6; TNF |
26.26 |
1 |
| 202. |
lactacystin
|
Diabetes Mellitus, Type 2
|
|
Via 3 genes: IL6; INS1; MAPK8IP1 |
26.11 |
2 |
| 203. |
2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine
|
Entamoebiasis
|
|
Via 2 genes: IL10; IL2 |
26.09 |
1 |
| 204. |
Acetylcysteine
|
Colitis, Ulcerative
|
|
Via 4 genes: IL1B; IL8; RELA; STAT3 |
25.98 |
3 |
| 205. |
Buthionine Sulfoximine
|
Berylliosis
|
|
Via 3 genes: GCLM; IL6; TNF |
25.98 |
5 |
| 206. |
lactacystin
|
Parkinson Disease
|
|
Via 3 genes: PARK7; SNCA; SOD1 |
25.92 |
13 |
| 207. |
Ethionine
|
Hyperlipoproteinemia Type II
|
|
Via 3 genes: APOA4; LIPC; PON2 |
25.70 |
1 |
| 208. |
lactacystin
|
Fever
|
|
Via 3 genes: IL6; IL8; TNF |
25.52 |
1 |
| 209. |
S-Nitroso-N-Acetylpenicillamine
|
Autistic Disorder
|
|
Via 4 genes: BCL2; CALCA; GPX1; IFNG |
25.51 |
4 |
| 210. |
S-Adenosylmethionine
|
Sepsis
|
|
Via 3 genes: MAPK1; MAPK3; TGFB1 |
25.38 |
2 |
| 211. |
Thiopronine
|
Myocardial Stunning
|
|
Via 2 genes: NOS2; TNF |
25.34 |
1 |
| 212. |
S-nitro-N-acetylpenicillamine
|
Colorectal Neoplasms
|
|
Via 3 genes: BIRC5; PTGS2; SMAD4 |
25.24 |
5 |
| 213. |
S-Adenosylmethionine
|
Osteoporosis
|
|
Via 3 genes: COL1A1; COL1A2; TGFB1 |
25.23 |
2 |
| 214. |
selenomethylselenocysteine
|
Infertility, Male
|
|
Via 3 genes: AR; GPX4; SEPP1 |
25.23 |
4 |
| 215. |
Acetylcysteine
|
Leukemia
|
|
Via 4 genes: AR; BCL2; CCND1; MGMT |
25.18 |
4 |
| 216. |
Buthionine Sulfoximine
|
Osteoporosis, Postmenopausal
|
|
Via 3 genes: CAT; IL6; TNF |
25.18 |
2 |
| 217. |
N-Formylmethionine Leucyl-Phenylalanine
|
Sepsis
|
|
Via 3 genes: MAPK1; MAPK3; TNF |
25.15 |
1 |
| 218. |
S-Nitroso-N-Acetylpenicillamine
|
Hypertension
|
|
Via 3 genes: EDN1; ELN; NPPA |
25.14 |
6 |
| 219. |
Acetylcysteine
|
Bone Neoplasms
|
|
Via 3 genes: MMP2; MMP9; PLAU |
25.09 |
1 |
| 220. |
Buthionine Sulfoximine
|
Carcinoma, Hepatocellular
|
|
Via 4 genes: CYP1A1; FOS; IL6; TP53 |
25.01 |
6 |
| 221. |
Acetylcysteine
|
Osteochondrodysplasias
|
|
Via 3 genes: BCL2; FLT1; KDR |
24.97 |
1 |
| 222. |
S-Adenosylmethionine
|
Lung Neoplasms
|
|
Via 4 genes: CYP2E1; MAPK1; MAPK3; TGFB1 |
24.94 |
7 |
| 223. |
Thiopronine
|
PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL
|
|
Via 2 genes: NOS2; TNF |
24.83 |
1 |
| 224. |
Ethionine
|
Autistic Disorder
|
|
Via 4 genes: CADPS2; GPX1; IGF1; MYO1D |
24.70 |
4 |
| 225. |
Homocysteine
|
Sepsis
|
|
Via 3 genes: MAPK1; MAPK3; MMP9 |
24.66 |
2 |
| 226. |
N-Formylmethionine Leucyl-Phenylalanine
|
Liver Cirrhosis, Experimental
|
|
Via 4 genes: IL1B; PTGS2; TNF; VEGFA |
24.65 |
4 |
| 227. |
S-allylcysteine
|
Colorectal Neoplasms
|
|
Via 3 genes: BCL2; CASP8; CDH1 |
24.64 |
3 |
| 228. |
Acetylcysteine
|
PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL
|
|
Via 3 genes: ICAM1; NOS2; TNF |
24.57 |
1 |
| 229. |
S-Nitroso-N-Acetylpenicillamine
|
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1
|
|
Via 2 genes: SFTPB; SFTPC |
24.53 |
1 |
| 230. |
Cysteine
|
Craniofacial Abnormalities
|
|
Via 3 genes: COL2A1; TGFB2; TGFBR2 |
24.50 |
5 |
| 231. |
FTI 277
|
Breast Neoplasms
|
|
Via 3 genes: CDKN1B; FGF10; RB1 |
24.48 |
3 |
| 232. |
5-S-glutathionyl-alpha-methyldopa
|
Prostatic Neoplasms
|
|
Via 3 genes: GSTA1; GSTM1; GSTP1 |
24.45 |
5 |
| 233. |
5-S-glutathionyldopamine
|
Prostatic Neoplasms
|
|
Via 3 genes: GSTA1; GSTM1; GSTP1 |
24.45 |
5 |
| 234. |
S-Nitroso-N-Acetylpenicillamine
|
Mesothelioma
|
|
Via 3 genes: FGF2; IFNG; SOD2 |
24.37 |
4 |
| 235. |
Buthionine Sulfoximine
|
Sepsis
|
|
Via 3 genes: CASP3; IL10; TNF |
24.36 |
3 |
| 236. |
Acetylcysteine
|
Osteosarcoma
|
|
Via 3 genes: CHEK2; JUN; TP53 |
24.35 |
5 |
| 237. |
S-Adenosylmethionine
|
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE
|
|
Via 2 genes: MTHFD1; MTR |
24.26 |
1 |
| 238. |
Homocysteine
|
Glioblastoma
|
|
Via 3 genes: BCHE; MMP9; VEGFA |
24.21 |
3 |
| 239. |
S-Nitroso-N-Acetylpenicillamine
|
Head and Neck Neoplasms
|
|
Via 3 genes: GPX1; MAPK1; MAPK3 |
24.18 |
2 |
| 240. |
Buthionine Sulfoximine
|
Crohn Disease
|
|
Via 3 genes: IL12B; IL6; TNF |
24.12 |
2 |
| 241. |
S-Nitroso-N-Acetylpenicillamine
|
LIPOID CONGENITAL ADRENAL HYPERPLASIA
|
|
Via 2 genes: CYP11A1; STAR |
24.12 |
1 |
| 242. |
Methionine
|
Craniofacial Abnormalities
|
|
Via 3 genes: COL2A1; TGFB2; TGFBR2 |
24.09 |
5 |
| 243. |
Cysteine
|
Urinary Bladder Neoplasms
|
|
Via 3 genes: GSTM1; GSTP1; RB1 |
23.81 |
3 |
| 244. |
Acetylcysteine
|
Intestinal Polyps
|
|
Via 3 genes: CCND1; JUN; PTGS2 |
23.78 |
4 |
| 245. |
Homocysteine
|
Neoplasm Metastasis
|
|
Via 3 genes: MMP9; MTHFR; TP53 |
23.71 |
3 |
| 246. |
N-Formylmethionine Leucyl-Phenylalanine
|
Arsenic Poisoning
|
|
Via 3 genes: IL1B; TNF; TNFAIP6 |
23.66 |
1 |
| 247. |
N-Formylmethionine Leucyl-Phenylalanine
|
Glioblastoma
|
|
Via 3 genes: IL1B; IL8; VEGFA |
23.65 |
1 |
| 248. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Leukemia, Myeloid, Acute
|
|
Via 3 genes: CEBPA; FHL2; HSPB1 |
23.62 |
2 |
| 249. |
Homocysteine
|
OROFACIAL CLEFT 1
|
|
Via 2 genes: MTHFR; MTR |
23.56 |
1 |
| 250. |
Homocysteine
|
Malnutrition
|
|
Via 2 genes: MTHFR; MTR |
23.56 |
1 |
| 251. |
Homocysteine
|
Hypertension
|
|
Via 3 genes: EDN1; NOS3; SOD3 |
23.53 |
7 |
| 252. |
Homocysteine
|
Hernia, Diaphragmatic
|
|
Via 3 genes: EDN1; NOS3; VCAM1 |
23.46 |
5 |
| 253. |
N,N-diacetylcystine
|
Multiple Sclerosis
|
|
Via 2 genes: IL2RA; PTPRC |
23.38 |
4 |
| 254. |
S-Adenosylmethionine
|
OSTEOGENESIS IMPERFECTA, TYPE IV
|
|
Via 2 genes: COL1A1; COL1A2 |
23.31 |
1 |
| 255. |
S-Adenosylmethionine
|
EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT
|
|
Via 2 genes: COL1A1; COL1A2 |
23.31 |
1 |
| 256. |
Homocysteine
|
Head and Neck Neoplasms
|
|
Via 3 genes: GPX1; MAPK1; MAPK3 |
23.31 |
2 |
| 257. |
N-Formylmethionine Leucyl-Phenylalanine
|
Psoriasis
|
|
Via 3 genes: IL6; TNF; VEGFA |
23.27 |
2 |
| 258. |
S-Nitroso-N-Acetylpenicillamine
|
Idiopathic Pulmonary Fibrosis
|
|
Via 2 genes: SFTPA1; SFTPC |
23.25 |
1 |
| 259. |
Acetylcysteine
|
Diabetic Nephropathies
|
|
Via 3 genes: KDR; TGFB1; VEGFA |
23.20 |
2 |
| 260. |
Buthionine Sulfoximine
|
Glioma
|
|
Via 3 genes: MGMT; PPARG; TP53 |
23.15 |
3 |
| 261. |
Buthionine Sulfoximine
|
Myocardial Infarction
|
|
Via 3 genes: GCLC; GCLM; NOS2 |
23.11 |
5 |
| 262. |
Methionine
|
Hernia, Diaphragmatic
|
|
Via 3 genes: IGF1; TGFB1; TNF |
23.01 |
3 |
| 263. |
lactacystin
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Via 3 genes: CCND1; IL6; TP53 |
23.00 |
3 |
| 264. |
lactacystin
|
Carcinoma, Squamous Cell
|
|
Via 3 genes: HIF1A; IL8; NFE2L2 |
22.94 |
3 |
| 265. |
Acetylcysteine
|
Carotid Artery Diseases
|
|
Via 3 genes: CCL2; HMOX1; TP53 |
22.92 |
3 |
| 266. |
S-nitro-N-acetylpenicillamine
|
Carcinoma, Hepatocellular
|
|
Via 3 genes: BIRC5; IL6; PTGS2 |
22.87 |
3 |
| 267. |
Acetylcysteine
|
Myocardial Reperfusion Injury
|
|
Via 3 genes: ATP2A2; EDN1; NOS2 |
22.86 |
3 |
| 268. |
alliin
|
Myocardial Ischemia
|
|
Via 2 genes: FGF2; VEGFA |
22.83 |
4 |
| 269. |
Acetylcysteine
|
Inflammation
|
|
Via 4 genes: HMOX1; NGF; NOS2; TNF |
22.74 |
4 |
| 270. |
Acetylcysteine
|
Cardiomyopathies
|
|
Via 3 genes: HGF; OLR1; PTGS2 |
22.74 |
4 |
| 271. |
lactacystin
|
Psoriasis
|
|
Via 3 genes: IL6; TNF; TP53 |
22.66 |
2 |
| 272. |
S-Nitroso-N-Acetylpenicillamine
|
Ovarian Neoplasms
|
|
Via 3 genes: AQP3; MAPK1; MAPK3 |
22.65 |
2 |
| 273. |
lactacystin
|
Hernia, Diaphragmatic
|
|
Via 3 genes: AGT; IL6; TNF |
22.58 |
3 |
| 274. |
Buthionine Sulfoximine
|
Leukemia
|
|
Via 3 genes: BCL2; CCND1; MGMT |
22.55 |
3 |
| 275. |
Selenomethionine
|
Carcinoma, Non-Small-Cell Lung
|
|
Via 3 genes: DUSP3; IL8; TP53 |
22.53 |
3 |
| 276. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Leukemia
|
|
Via 3 genes: BIRC3; CCND1; TOP2A |
22.52 |
3 |
| 277. |
N-(3-nitratopivaloyl)cysteine ethyl ester
|
Cardiovascular Diseases
|
|
Via 2 genes: ICAM1; SELE |
22.50 |
1 |
| 278. |
S-allylcysteine
|
Lung Neoplasms
|
|
Via 3 genes: CASP8; NOS2; TGFB1 |
22.45 |
6 |
| 279. |
selenomethylselenocysteine
|
OSTEOGENESIS IMPERFECTA, TYPE IV
|
|
Via 2 genes: COL1A1; COL1A2 |
22.42 |
1 |
| 280. |
selenomethylselenocysteine
|
EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT
|
|
Via 2 genes: COL1A1; COL1A2 |
22.42 |
1 |
| 281. |
lactacystin
|
Esophageal Neoplasms
|
|
Via 3 genes: CCND1; HIF1A; TP53 |
22.42 |
3 |
| 282. |
Selenomethionine
|
Arsenic Poisoning
|
|
Via 3 genes: IL1B; SSBP1; TP53 |
22.37 |
3 |
| 283. |
Acetylcysteine
|
Carcinoma, Adenoid Cystic
|
|
Via 3 genes: CCND1; DAPK1; JAG1 |
22.32 |
1 |
| 284. |
Selenomethionine
|
Melanoma
|
|
Via 3 genes: COL2A1; STX17; TP53 |
22.27 |
3 |
| 285. |
Acetylcysteine
|
Salivary Gland Neoplasms
|
|
Via 3 genes: CCND1; DAPK1; JAG1 |
22.26 |
1 |
| 286. |
Thiopronine
|
Malaria
|
|
Via 2 genes: NOS2; TNF |
22.22 |
1 |
| 287. |
N-Formylmethionine Leucyl-Phenylalanine
|
Asthma
|
|
Via 3 genes: ALOX5; TNF; VEGFA |
22.16 |
6 |
| 288. |
S-Adenosylmethionine
|
Breast Neoplasms
|
|
Via 3 genes: AFP; COMT; MTR |
22.15 |
5 |
| 289. |
lactacystin
|
Pulmonary Fibrosis
|
|
Via 3 genes: IL6; IL8; TNF |
22.12 |
4 |
| 290. |
2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine
|
HIV Infections
|
|
Via 2 genes: IL10; IL2 |
22.07 |
2 |
| 291. |
Acetylcysteine
|
Diabetes Mellitus
|
|
Via 3 genes: ADIPOQ; CAT; PTGS2 |
22.06 |
3 |
| 292. |
Buthionine Sulfoximine
|
Reperfusion Injury
|
|
Via 3 genes: CDKN1A; IL10; TNF |
22.05 |
3 |
| 293. |
S-Adenosylhomocysteine
|
Oral Submucous Fibrosis
|
|
Via 2 genes: COL1A1; COL1A2 |
22.04 |
1 |
| 294. |
N,N-diacetylcystine
|
Berylliosis
|
|
Via 2 genes: IL2RA; TNF |
22.00 |
5 |
| 295. |
Buthionine Sulfoximine
|
Carcinoma, Non-Small-Cell Lung
|
|
Via 3 genes: GCLC; NQO1; TP53 |
21.99 |
3 |
| 296. |
Acetylcysteine
|
Bronchial Hyperreactivity
|
|
Via 3 genes: CCL2; CXCL1; ICAM1 |
21.97 |
2 |
| 297. |
lactacystin
|
Pancreatic Neoplasms
|
|
Via 3 genes: HIF1A; TNF; TP53 |
21.93 |
4 |
| 298. |
Acetylcysteine
|
Pulmonary Disease, Chronic Obstructive
|
|
Via 3 genes: HMOX1; TGFB1; TP53 |
21.83 |
4 |
| 299. |
S-Nitroso-N-Acetylpenicillamine
|
Diabetes Mellitus, Type 2
|
|
Via 3 genes: EDN1; HMOX1; NFKB1 |
21.82 |
3 |
| 300. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Ovarian Neoplasms
|
|
Via 3 genes: ATF3; BIRC5; GADD45A |
21.79 |
6 |
| 301. |
Acetylcysteine
|
Respiratory Hypersensitivity
|
|
Via 3 genes: IL6; SLC39A14; TNF |
21.77 |
2 |
| 302. |
Ethionine
|
Craniofacial Abnormalities
|
|
Via 3 genes: ATP6AP2; TMCO1; UFD1L |
21.76 |
3 |
| 303. |
S-Adenosylmethionine
|
Ovarian Neoplasms
|
|
Via 3 genes: ATF3; MAPK1; MAPK3 |
21.70 |
2 |
| 304. |
Acetylcysteine
|
Intestinal Neoplasms
|
|
Via 3 genes: BAX; BCL2; CDKN1A |
21.65 |
4 |
| 305. |
Buthionine Sulfoximine
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Via 3 genes: CCND1; IL6; TP53 |
21.65 |
3 |
| 306. |
N-Formylmethionine Leucyl-Phenylalanine
|
Melanoma
|
|
Via 3 genes: PTGS2; RAC2; TNF |
21.65 |
3 |
| 307. |
selenomethylselenocysteine
|
Liver Neoplasms
|
|
Via 3 genes: CDKN1B; ESR1; TNFSF10 |
21.57 |
3 |
| 308. |
N-Formylmethionine Leucyl-Phenylalanine
|
Carcinoma, Squamous Cell
|
|
Via 3 genes: IL8; PTGS2; VEGFA |
21.51 |
3 |
| 309. |
Cysteine
|
Carcinoma, Hepatocellular
|
|
Via 3 genes: GSTP1; RB1; TGFB1 |
21.40 |
2 |
| 310. |
Homocysteine
|
Carcinoma, Squamous Cell
|
|
Via 3 genes: GPX1; MMP9; VEGFA |
21.39 |
3 |
| 311. |
Ethionine
|
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA
|
|
Via 2 genes: SDHC; SDHD |
21.38 |
1 |
| 312. |
N-Formylmethionine Leucyl-Phenylalanine
|
Colonic Neoplasms
|
|
Via 3 genes: ALOX5; IL1B; VEGFA |
21.37 |
2 |
| 313. |
N-Formylmethionine Leucyl-Phenylalanine
|
Ovarian Neoplasms
|
|
Via 3 genes: AKT1; MAPK1; MAPK3 |
21.32 |
1 |
| 314. |
Homocysteine
|
Stomach Neoplasms
|
|
Via 3 genes: DNMT1; MTHFR; NOS3 |
21.12 |
3 |
| 315. |
Homocysteine
|
Diabetes Mellitus, Type 2
|
|
Via 3 genes: CAT; EDN1; VEGFA |
21.11 |
3 |
| 316. |
N-Formylmethionine Leucyl-Phenylalanine
|
Arthritis, Rheumatoid
|
|
Via 3 genes: PTGS2; TNF; VEGFA |
21.02 |
4 |
| 317. |
S-nitro-N-acetylpenicillamine
|
Autistic Disorder
|
|
Via 3 genes: CALCA; IL6; PTGS2 |
20.98 |
3 |
| 318. |
Cysteine
|
Eye Abnormalities
|
|
Via 2 genes: TGFB2; TGFBR2 |
20.92 |
2 |
| 319. |
Buthionine Sulfoximine
|
Arsenic Poisoning
|
|
Via 3 genes: SOD2; TNF; TP53 |
20.86 |
3 |
| 320. |
S-Nitroso-N-Acetylpenicillamine
|
Liver Diseases
|
|
Via 3 genes: HMOX1; NFKB1; SOD1 |
20.82 |
5 |
| 321. |
S-(1,2-dichlorovinyl)cysteine
|
Breast Neoplasms
|
|
Via 3 genes: BCL2; JUN; TP53 |
20.79 |
8 |
| 322. |
Selenomethionine
|
Colitis, Ulcerative
|
|
Via 3 genes: IL1B; IL8; RELA |
20.78 |
1 |
| 323. |
Buthionine Sulfoximine
|
Pulmonary Fibrosis
|
|
Via 3 genes: HMOX1; IL6; TNF |
20.75 |
4 |
| 324. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Carcinoma, Squamous Cell
|
|
Via 3 genes: CDKN1A; CEBPA; VEGFA |
20.74 |
3 |
| 325. |
Acetylcysteine
|
Parkinson Disease
|
|
Via 3 genes: PARK7; SNCA; SOD1 |
20.73 |
13 |
| 326. |
N-Formylmethionine Leucyl-Phenylalanine
|
Alzheimer Disease
|
|
Via 3 genes: IL1B; MPO; TNF |
20.71 |
3 |
| 327. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Asthma
|
|
Via 3 genes: CD14; HMOX1; VEGFA |
20.67 |
4 |
| 328. |
Methionine
|
Eye Abnormalities
|
|
Via 2 genes: TGFB2; TGFBR2 |
20.64 |
2 |
| 329. |
Buthionine Sulfoximine
|
Pancreatic Neoplasms
|
|
Via 3 genes: HIF1A; TNF; TP53 |
20.59 |
4 |
| 330. |
S-nitro-N-acetylpenicillamine
|
Intestinal Polyps
|
|
Via 2 genes: JUN; PTGS2 |
20.57 |
4 |
| 331. |
Homocysteine
|
Diabetic Angiopathies
|
|
Via 2 genes: MTHFR; NOS3 |
20.46 |
2 |
| 332. |
Ethionine
|
Liver Diseases
|
|
Via 3 genes: AFP; OBP3; SERPINA1 |
20.43 |
4 |
| 333. |
Acetylcysteine
|
Malaria
|
|
Via 3 genes: ICAM1; NOS2; TNF |
20.42 |
1 |
| 334. |
lactacystin
|
Alzheimer Disease
|
|
Via 3 genes: APP; CASP3; TNF |
20.35 |
14 |
| 335. |
S-Adenosylhomocysteine
|
Osteoporosis
|
|
Via 2 genes: COL1A1; COL1A2 |
20.27 |
1 |
| 336. |
glutamyl-Se-methylselenocysteine
|
Pulmonary Fibrosis
|
|
Via 2 genes: CMA1; CXCL2 |
20.24 |
2 |
| 337. |
lactacystin
|
Cecal Neoplasms
|
|
Via 2 genes: CCND1; CTNNB1 |
20.24 |
1 |
| 338. |
S-(1,2-dichlorovinyl)cysteine
|
Osteosarcoma
|
|
Via 2 genes: JUN; TP53 |
20.23 |
4 |
| 339. |
Ethionine
|
Obesity
|
|
Via 3 genes: ENPP1; GPX1; ME1 |
20.19 |
3 |
| 340. |
Acetylcysteine
|
Duodenal Ulcer
|
|
Via 3 genes: NOS2; PTGS2; TGFB1 |
20.12 |
3 |
| 341. |
Selenomethionine
|
Urinary Bladder Neoplasms
|
|
Via 3 genes: EGFR; GSTP1; TP53 |
20.03 |
4 |
| 342. |
Homocysteine
|
Down Syndrome
|
|
Via 2 genes: MTHFR; MTR |
20.02 |
5 |
| 343. |
Acetylcysteine
|
Kidney Neoplasms
|
|
Via 3 genes: CYP1A1; PTGS2; TNFSF10 |
20.02 |
3 |
| 344. |
N-Formylmethionine Leucyl-Phenylalanine
|
Drug-Induced Liver Injury
|
|
Via 3 genes: IL1B; IL6; PTGS2 |
20.02 |
3 |
| 345. |
Acetylcysteine
|
OSTEOGENESIS IMPERFECTA, TYPE IV
|
|
Via 2 genes: COL1A1; COL1A2 |
19.98 |
1 |
| 346. |
Acetylcysteine
|
EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT
|
|
Via 2 genes: COL1A1; COL1A2 |
19.98 |
1 |
| 347. |
Thiopronine
|
Stomach Ulcer
|
|
Via 2 genes: NOS2; TNF |
19.94 |
2 |
| 348. |
Buthionine Sulfoximine
|
Drug-Induced Liver Injury
|
|
Via 3 genes: GCLC; HMOX1; IL6 |
19.84 |
3 |
| 349. |
S-(1,2-dichlorovinyl)cysteine
|
Intestinal Neoplasms
|
|
Via 2 genes: BAX; BCL2 |
19.84 |
2 |
| 350. |
S-nitro-N-acetylpenicillamine
|
Arthritis, Experimental
|
|
Via 2 genes: CALCA; STAT3 |
19.82 |
2 |
| 351. |
Homocysteine
|
Hypertension, Portal
|
|
Via 2 genes: NOS3; VEGFA |
19.81 |
2 |
| 352. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Diabetes Mellitus, Type 2
|
|
Via 3 genes: HMOX1; PPARG; VEGFA |
19.75 |
2 |
| 353. |
selenomethylselenocysteine
|
Colonic Neoplasms
|
|
Via 3 genes: BCL2; CCND1; TNFSF10 |
19.68 |
3 |
| 354. |
Buthionine Sulfoximine
|
Hypothermia
|
|
Via 2 genes: IL12B; TNF |
19.66 |
1 |
| 355. |
Ethionine
|
Hernia, Diaphragmatic
|
|
Via 3 genes: AGT; AGTR1A; IGF1 |
19.63 |
2 |
| 356. |
selenomethylselenocysteine
|
Carcinoma, Hepatocellular
|
|
Via 3 genes: AR; ESR1; IGF1R |
19.60 |
3 |
| 357. |
Buthionine Sulfoximine
|
Schistosomiasis mansoni
|
|
Via 2 genes: NOS2; SOD1 |
19.58 |
2 |
| 358. |
selenomethylselenocysteine
|
Chondrosarcoma, Mesenchymal
|
|
Via 2 genes: BCL2; MKI67 |
19.57 |
1 |
| 359. |
Ethionine
|
Paraganglioma
|
|
Via 2 genes: SDHC; SDHD |
19.48 |
2 |
| 360. |
Homocysteine
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Via 2 genes: MTHFR; MTRR |
19.43 |
2 |
| 361. |
S-Nitroso-N-Acetylpenicillamine
|
Carcinoma, Small Cell
|
|
Via 2 genes: NPPA; TP53 |
19.42 |
2 |
| 362. |
S-Nitroso-N-Acetylpenicillamine
|
Colonic Neoplasms
|
|
Via 3 genes: BCL2; IFNG; TP53 |
19.41 |
5 |
| 363. |
N-Formylmethionine Leucyl-Phenylalanine
|
Multiple Organ Failure
|
|
Via 2 genes: ALOX5; TNF |
19.41 |
2 |
| 364. |
Ethionine
|
Glucose Intolerance
|
|
Via 2 genes: AGTR1A; LIPC |
19.37 |
2 |
| 365. |
alliin
|
Psoriasis
|
|
Via 2 genes: TP53; VEGFA |
19.32 |
2 |
| 366. |
5-S-glutathionyldopamine
|
Urinary Bladder Neoplasms
|
|
Via 2 genes: GSTM1; GSTP1 |
19.32 |
2 |
| 367. |
5-S-glutathionyl-alpha-methyldopa
|
Urinary Bladder Neoplasms
|
|
Via 2 genes: GSTM1; GSTP1 |
19.32 |
2 |
| 368. |
S-nitro-N-acetylpenicillamine
|
Cholangiocarcinoma
|
|
Via 2 genes: IL6; PTGS2 |
19.31 |
2 |
| 369. |
Cysteine
|
Pulmonary Emphysema
|
|
Via 2 genes: HMOX1; TGFB1 |
19.29 |
3 |
| 370. |
FTI 277
|
Ovarian Neoplasms
|
|
Via 2 genes: CDKN1B; RBL2 |
19.24 |
2 |
| 371. |
Methionine
|
Hyperhomocysteinemia
|
|
Via 2 genes: MTRR; TNF |
19.20 |
3 |
| 372. |
Methionine
|
Myocardial Stunning
|
|
Via 2 genes: NOS2; TNF |
19.20 |
1 |
| 373. |
Acetylcysteine
|
Kidney Diseases
|
|
Via 3 genes: CDKN1A; TERT; TGFB1 |
19.14 |
2 |
| 374. |
Acetylcysteine
|
Head and Neck Neoplasms
|
|
Via 3 genes: EGFR; MAPK1; MAPK3 |
19.11 |
1 |
| 375. |
S-(1,2-dichlorovinyl)cysteine
|
Carcinoma, Renal Cell
|
|
Via 2 genes: APAF1; TP53 |
19.10 |
2 |
| 376. |
lactacystin
|
Liver Cirrhosis, Experimental
|
|
Via 3 genes: AGT; GSTA2; TNF |
19.08 |
3 |
| 377. |
Selenomethionine
|
Ovarian Neoplasms
|
|
Via 3 genes: EGFR; MAPK1; MAPK3 |
19.01 |
1 |
| 378. |
5-S-glutathionyl-alpha-methyldopa
|
Asthma
|
|
Via 2 genes: GSTM1; GSTP1 |
18.99 |
3 |
| 379. |
5-S-glutathionyldopamine
|
Asthma
|
|
Via 2 genes: GSTM1; GSTP1 |
18.99 |
3 |
| 380. |
selenomethylselenocysteine
|
Stomach Neoplasms
|
|
Via 3 genes: CDKN1B; GADD45A; JUN |
18.99 |
3 |
| 381. |
Cysteine
|
Osteosarcoma
|
|
Via 2 genes: GSTP1; RB1 |
18.95 |
2 |
| 382. |
Buthionine Sulfoximine
|
Inflammation
|
|
Via 3 genes: HMOX1; NOS2; TNF |
18.95 |
3 |
| 383. |
Cysteine
|
Carotid Artery Diseases
|
|
Via 2 genes: GSTP1; HMOX1 |
18.92 |
2 |
| 384. |
methylmercury cysteine
|
Endometrial Neoplasms
|
|
Via 2 genes: BIRC5; SUZ12 |
18.91 |
2 |
| 385. |
N-Formylmethionine Leucyl-Phenylalanine
|
Autistic Disorder
|
|
Via 3 genes: IL6; PLA2G4A; PTGS2 |
18.90 |
3 |
| 386. |
Acetylcysteine
|
Hypertrophy, Left Ventricular
|
|
Via 2 genes: CKM; HBEGF |
18.87 |
2 |
| 387. |
Thiopronine
|
Inflammation
|
|
Via 2 genes: NOS2; TNF |
18.81 |
2 |
| 388. |
S-allylcysteine
|
Sepsis
|
|
Via 2 genes: CASP3; TGFB1 |
18.81 |
1 |
| 389. |
Buthionine Sulfoximine
|
Colonic Neoplasms
|
|
Via 3 genes: BCL2; CCND1; TP53 |
18.78 |
4 |
| 390. |
Methionine
|
PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL
|
|
Via 2 genes: NOS2; TNF |
18.69 |
1 |
| 391. |
S-allylcysteine
|
Duodenal Ulcer
|
|
Via 2 genes: NOS2; TGFB1 |
18.66 |
3 |
| 392. |
Methionine
|
Myocardial Reperfusion Injury
|
|
Via 2 genes: CYBB; NOS2 |
18.60 |
1 |
| 393. |
2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine
|
Autistic Disorder
|
|
Via 2 genes: IL10; IL2 |
18.52 |
2 |
| 394. |
alliin
|
Carcinoma, Non-Small-Cell Lung
|
|
Via 2 genes: TP53; VEGFA |
18.42 |
2 |
| 395. |
Selenocysteine
|
Colitis, Ulcerative
|
|
Via 2 genes: IL8; RELA |
18.40 |
1 |
| 396. |
Acetylcysteine
|
Aortic Aneurysm
|
|
Via 2 genes: MMP9; TGFBR2 |
18.38 |
2 |
| 397. |
selenomethylselenocysteine
|
Alzheimer Disease
|
|
Via 3 genes: BCL2; CASP3; ESR1 |
18.37 |
2 |
| 398. |
N-Formylmethionine Leucyl-Phenylalanine
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Via 2 genes: ALOX5; MAPK14 |
18.36 |
3 |
| 399. |
Ethionine
|
Anemia, Diamond-Blackfan
|
|
Via 2 genes: RPL11; RPS19 |
18.35 |
2 |
| 400. |
Acetylcysteine
|
Li-Fraumeni Syndrome
|
|
Via 2 genes: CHEK2; TP53 |
18.33 |
4 |
| 401. |
N-Formylmethionine Leucyl-Phenylalanine
|
Entamoebiasis
|
|
Via 2 genes: IL1B; IL6 |
18.32 |
1 |
| 402. |
Homocysteine
|
Lymphoma
|
|
Via 2 genes: MTHFR; MTR |
18.32 |
1 |
| 403. |
Thiorphan
|
Prostatic Neoplasms
|
|
Via 2 genes: AKT1; MME |
18.30 |
2 |
| 404. |
Homocysteine
|
Hyperinsulinism
|
|
Via 2 genes: GPX1; NOS3 |
18.29 |
3 |
| 405. |
Buthionine Sulfoximine
|
Intestinal Polyps
|
|
Via 2 genes: CCND1; JUN |
18.26 |
1 |
| 406. |
Buthionine Sulfoximine
|
Myocardial Stunning
|
|
Via 2 genes: NOS2; TNF |
18.23 |
1 |
| 407. |
Ethionine
|
Asbestosis
|
|
Via 2 genes: GSTT1; SERPINA1 |
18.23 |
2 |
| 408. |
selenomethylselenocysteine
|
Prostatic Intraepithelial Neoplasia
|
|
Via 2 genes: AR; ESR1 |
18.22 |
2 |
| 409. |
N-Formylmethionine Leucyl-Phenylalanine
|
Dermatomyositis
|
|
Via 2 genes: IL1B; TNF |
18.22 |
1 |
| 410. |
Cysteine
|
Pulmonary Disease, Chronic Obstructive
|
|
Via 2 genes: HMOX1; TGFB1 |
18.15 |
3 |
| 411. |
Methionine
|
Female Urogenital Diseases
|
|
Via 2 genes: IGF1; TIMP1 |
18.04 |
1 |
| 412. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Muscular Dystrophy, Facioscapulohumeral
|
|
Via 2 genes: CDKN1A; HSPA1B |
17.99 |
1 |
| 413. |
Acetylcysteine
|
Bronchiectasis
|
|
Via 2 genes: ICAM1; TNF |
17.97 |
1 |
| 414. |
Buthionine Sulfoximine
|
Entamoebiasis
|
|
Via 2 genes: IL10; IL6 |
17.97 |
1 |
| 415. |
N,N-diacetylcystine
|
Hernia, Diaphragmatic
|
|
Via 2 genes: NOS3; TNF |
17.92 |
3 |
| 416. |
selenomethylselenocysteine
|
Intestinal Polyps
|
|
Via 2 genes: CCND1; JUN |
17.92 |
1 |
| 417. |
Acetylcysteine
|
HIV Infections
|
|
Via 3 genes: ALB; BAX; CDKN1A |
17.92 |
2 |
| 418. |
N-Formylmethionine Leucyl-Phenylalanine
|
Hypersensitivity
|
|
Via 2 genes: SELP; TNF |
17.88 |
2 |
| 419. |
Buthionine Sulfoximine
|
Multiple Organ Failure
|
|
Via 2 genes: IL10; TNF |
17.87 |
2 |
| 420. |
Buthionine Sulfoximine
|
Epilepsy
|
|
Via 2 genes: SEPW1; TXNRD1 |
17.86 |
1 |
| 421. |
Buthionine Sulfoximine
|
PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL
|
|
Via 2 genes: NOS2; TNF |
17.72 |
1 |
| 422. |
Acetylcysteine
|
Atrophy
|
|
Via 2 genes: MAPK3; STAT3 |
17.72 |
1 |
| 423. |
S-Nitroso-N-Acetylpenicillamine
|
Oral Submucous Fibrosis
|
|
Via 2 genes: FGF2; IFNG |
17.71 |
1 |
| 424. |
selenomethylselenocysteine
|
Oral Submucous Fibrosis
|
|
Via 2 genes: COL1A1; COL1A2 |
17.66 |
1 |
| 425. |
S-Nitroso-N-Acetylpenicillamine
|
Carotid Artery Diseases
|
|
Via 2 genes: HMOX1; TP53 |
17.65 |
2 |
| 426. |
S-Nitroso-N-Acetylpenicillamine
|
Wounds and Injuries
|
|
Via 2 genes: CALCA; HMOX1 |
17.64 |
2 |
| 427. |
S-Nitroso-N-Acetylpenicillamine
|
Cardiomyopathy, Dilated
|
|
Via 2 genes: CSRP3; GPX1 |
17.63 |
2 |
| 428. |
lactacystin
|
Mesothelioma
|
|
Via 2 genes: CDKN1B; DIO2 |
17.57 |
2 |
| 429. |
lactacystin
|
Hemangiosarcoma
|
|
Via 2 genes: CTNNB1; TP53 |
17.56 |
2 |
| 430. |
N-Formylmethionine Leucyl-Phenylalanine
|
Cholangiocarcinoma
|
|
Via 2 genes: IL6; PTGS2 |
17.53 |
2 |
| 431. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Myocardial Ischemia
|
|
Via 2 genes: HGF; VEGFA |
17.53 |
4 |
| 432. |
Homocysteine
|
Cell Transformation, Neoplastic
|
|
Via 2 genes: MMP9; WNT5A |
17.52 |
2 |
| 433. |
Buthionine Sulfoximine
|
Drug Toxicity
|
|
Via 2 genes: HMOX1; IGFBP1 |
17.49 |
2 |
| 434. |
S-nitro-N-acetylpenicillamine
|
Carcinoma, Renal Cell
|
|
Via 2 genes: BIRC5; PTGS2 |
17.44 |
2 |
| 435. |
Homocysteine
|
Myocardial Ischemia
|
|
Via 2 genes: NOS3; VEGFA |
17.42 |
4 |
| 436. |
S-(1,1,2,2-tetrafluoroethyl)cysteine
|
Endometrial Neoplasms
|
|
Via 2 genes: BIRC5; MSH6 |
17.40 |
2 |
| 437. |
S-nitro-N-acetylpenicillamine
|
Pulmonary Fibrosis
|
|
Via 2 genes: CALCA; IL6 |
17.36 |
2 |
| 438. |
2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteine
|
Prostatic Neoplasms
|
|
Via 2 genes: IL10; IL2 |
17.35 |
4 |
| 439. |
Buthionine Sulfoximine
|
Soft Tissue Neoplasms
|
|
Via 2 genes: BCL2; TNF |
17.35 |
3 |
| 440. |
Homocysteine
|
Carotid Artery Diseases
|
|
Via 2 genes: CCL2; TP53 |
17.35 |
2 |
| 441. |
selenomethylselenocysteine
|
Epilepsy
|
|
Via 2 genes: GPX1; SEPW1 |
17.34 |
1 |
| 442. |
Buthionine Sulfoximine
|
Occupational Diseases
|
|
Via 2 genes: CYP1A1; NQO1 |
17.33 |
4 |
| 443. |
lactacystin
|
Medulloblastoma
|
|
Via 2 genes: CCNE1; CTNNB1 |
17.33 |
2 |
| 444. |
Thiopronine
|
Lung Neoplasms
|
|
Via 2 genes: NOS2; TNF |
17.27 |
2 |
| 445. |
N-Formylmethionine Leucyl-Phenylalanine
|
Adenomatous Polyposis Coli
|
|
Via 2 genes: AKT1; PTGS2 |
17.23 |
1 |
| 446. |
Acetylcysteine
|
Eye Abnormalities
|
|
Via 2 genes: APAF1; TGFBR2 |
17.22 |
2 |
| 447. |
5-S-glutathionyl-alpha-methyldopa
|
Liver Cirrhosis, Experimental
|
|
Via 2 genes: GSTA2; GSTM1 |
17.19 |
2 |
| 448. |
5-S-glutathionyldopamine
|
Liver Cirrhosis, Experimental
|
|
Via 2 genes: GSTA2; GSTM1 |
17.19 |
2 |
| 449. |
Acetylcysteine
|
Gallbladder Neoplasms
|
|
Via 2 genes: BCL2; KEAP1 |
17.19 |
2 |
| 450. |
FTI 277
|
Urinary Bladder Neoplasms
|
|
Via 2 genes: CDKN1A; RB1 |
17.17 |
2 |
| 451. |
Buthionine Sulfoximine
|
Carotid Artery Diseases
|
|
Via 2 genes: HMOX1; TP53 |
17.15 |
2 |
| 452. |
Acetylcysteine
|
Hypertension, Portal
|
|
Via 2 genes: NOS3; VEGFA |
17.12 |
2 |
| 453. |
N-Formylmethionine Leucyl-Phenylalanine
|
Amyotrophic Lateral Sclerosis
|
|
Via 2 genes: PLA2G4A; PTGS2 |
17.12 |
1 |
| 454. |
S-Nitroso-N-Acetylpenicillamine
|
Coronary Artery Disease
|
|
Via 2 genes: GPX1; HMOX1 |
17.10 |
2 |
| 455. |
S-allylcysteine
|
Liver Diseases
|
|
Via 2 genes: JUP; NOS2 |
17.07 |
1 |
| 456. |
S-Nitroso-N-Acetylpenicillamine
|
Pulmonary Disease, Chronic Obstructive
|
|
Via 2 genes: HMOX1; TP53 |
17.05 |
3 |
| 457. |
Homocysteine
|
Adenoma
|
|
Via 2 genes: BCL2; MTRR |
17.03 |
3 |
| 458. |
Methionine
|
Berylliosis
|
|
Via 2 genes: TGFB1; TNF |
16.98 |
6 |
| 459. |
Thiopronine
|
Liver Cirrhosis, Experimental
|
|
Via 2 genes: NOS2; TNF |
16.97 |
2 |
| 460. |
Selenomethionine
|
Pulmonary Disease, Chronic Obstructive
|
|
Via 2 genes: MMP1; TP53 |
16.97 |
2 |
| 461. |
S-allylcysteine
|
Skin Neoplasms
|
|
Via 2 genes: CASP8; TGFB1 |
16.97 |
2 |
| 462. |
Buthionine Sulfoximine
|
Osteosarcoma
|
|
Via 2 genes: JUN; TP53 |
16.93 |
4 |
| 463. |
alliin
|
Colonic Neoplasms
|
|
Via 2 genes: TP53; VEGFA |
16.93 |
3 |
| 464. |
Cysteine
|
Fibrosis
|
|
Via 2 genes: HMOX1; TGFB1 |
16.90 |
3 |
| 465. |
S-Nitroso-N-Acetylpenicillamine
|
Retinal Degeneration
|
|
Via 2 genes: BCL2; SOD1 |
16.89 |
2 |
| 466. |
selenomethylselenocysteine
|
Autistic Disorder
|
|
Via 3 genes: AR; BCL2; GPX1 |
16.89 |
3 |
| 467. |
Selenomethionine
|
Stomach Neoplasms
|
|
Via 3 genes: EGFR; IL1B; IL8 |
16.89 |
3 |
| 468. |
S-(1,2-dichlorovinyl)cysteine
|
Liver Neoplasms, Experimental
|
|
Via 2 genes: BCL2; TP53 |
16.88 |
2 |
| 469. |
alliin
|
Liver Cirrhosis, Experimental
|
|
Via 2 genes: FGF2; VEGFA |
16.88 |
3 |
| 470. |
S-Nitroso-N-Acetylpenicillamine
|
Cardiomegaly
|
|
Via 2 genes: FGF2; NPPA |
16.87 |
2 |
| 471. |
Acetylcysteine
|
Glomerulonephritis, IGA
|
|
Via 2 genes: AGT; SELE |
16.86 |
2 |
| 472. |
Acetylcysteine
|
Schistosomiasis mansoni
|
|
Via 2 genes: NOS2; SOD1 |
16.81 |
2 |
| 473. |
N-Formylmethionine Leucyl-Phenylalanine
|
Coronary Artery Disease
|
|
Via 2 genes: PTGS2; VEGFA |
16.78 |
2 |
| 474. |
lactacystin
|
Adenoma
|
|
Via 2 genes: BCL2L1; CTNNB1 |
16.76 |
2 |
| 475. |
Acetylcysteine
|
Cerebral Hemorrhage
|
|
Via 2 genes: HMOX1; MMP9 |
16.76 |
2 |
| 476. |
Methionine
|
Duodenal Ulcer
|
|
Via 2 genes: NOS2; TGFB1 |
16.72 |
3 |
| 477. |
Selenomethionine
|
Carcinoma, Basal Cell
|
|
Via 2 genes: TP53; XPA |
16.66 |
2 |
| 478. |
lactacystin
|
Osteoporosis, Postmenopausal
|
|
Via 2 genes: IL6; TNF |
16.66 |
1 |
| 479. |
Buthionine Sulfoximine
|
Cholangiocarcinoma
|
|
Via 2 genes: IL6; NOS2 |
16.66 |
2 |
| 480. |
Selenomethionine
|
Carotid Artery Diseases
|
|
Via 2 genes: GSTP1; TP53 |
16.56 |
1 |
| 481. |
Buthionine Sulfoximine
|
Intestinal Neoplasms
|
|
Via 2 genes: BCL2; CDKN1A |
16.56 |
3 |
| 482. |
N-Formylmethionine Leucyl-Phenylalanine
|
Berylliosis
|
|
Via 2 genes: IL6; TNF |
16.56 |
4 |
| 483. |
Buthionine Sulfoximine
|
Pulmonary Disease, Chronic Obstructive
|
|
Via 2 genes: HMOX1; TP53 |
16.55 |
3 |
| 484. |
Cysteine
|
Mesothelioma
|
|
Via 2 genes: CDKN1B; GSTM1 |
16.54 |
2 |
| 485. |
N,N-diacetylcystine
|
Alzheimer Disease
|
|
Via 2 genes: NOS3; TNF |
16.53 |
3 |
| 486. |
lactacystin
|
Berylliosis
|
|
Via 2 genes: IL6; TNF |
16.49 |
4 |
| 487. |
Acetylcysteine
|
Hyperinsulinism
|
|
Via 2 genes: INS; NOS3 |
16.49 |
2 |
| 488. |
Methionine
|
Schizophrenia
|
|
Via 2 genes: AKT1; RELN |
16.48 |
3 |
| 489. |
Homocysteine
|
Intestinal Neoplasms
|
|
Via 2 genes: BAX; BCL2 |
16.47 |
2 |
| 490. |
5-S-glutathionyldopamine
|
Autistic Disorder
|
|
Via 2 genes: GSTM1; GSTP1 |
16.45 |
2 |
| 491. |
5-S-glutathionyl-alpha-methyldopa
|
Autistic Disorder
|
|
Via 2 genes: GSTM1; GSTP1 |
16.45 |
2 |
| 492. |
Cysteine
|
Osteoporosis
|
|
Via 2 genes: COL1A1; TGFB1 |
16.43 |
2 |
| 493. |
Methionine
|
Migraine Disorders
|
|
Via 2 genes: TGFBR2; TNF |
16.40 |
2 |
| 494. |
Buthionine Sulfoximine
|
Retinal Degeneration
|
|
Via 2 genes: BCL2; SOD1 |
16.39 |
2 |
| 495. |
Homocysteine
|
Retinal Degeneration
|
|
Via 2 genes: BCL2; SOD1 |
16.32 |
2 |
| 496. |
Acetylcysteine
|
Metabolic Syndrome X
|
|
Via 2 genes: ADIPOQ; CCL2 |
16.32 |
4 |
| 497. |
S-allylcysteine
|
Esophageal Neoplasms
|
|
Via 2 genes: CASP8; NOS2 |
16.32 |
2 |
| 498. |
2-amino-4-methylthio-3-butenoic acid
|
METHIONINE ADENOSYLTRANSFERASE DEFICIENCY
|
|
Via 1 gene: MAT1A |
16.29 |
1 |
| 499. |
S-nitro-N-acetylpenicillamine
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Via 2 genes: IL6; PTGS2 |
16.28 |
2 |
| 500. |
lactacystin
|
Amyotrophic Lateral Sclerosis
|
|
Via 2 genes: SOD1; TP53 |
16.27 |
8 |